Genentech Wins Judge's OK Of $18M Novartis Award
A D.C. federal judge has enforced a nearly $18 million arbitral award against Novartis Pharma AG following its dispute with biotechnology firm Genentech Inc. over a licensing agreement for an eye...To view the full article, register now.
Already a subscriber? Click here to view full article